HRT Financial’s Biofrontera BFRI Stock Holding History

HRT Financial’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40K	Buy	+43,349	New	+$42.9K	﹤0.01%	3820
2025 Q3	–	Sell	-12,086	Closed	-$8K	–	2870
2025 Q2	$8K	Buy	+12,086	New	+$8.45K	﹤0.01%	2462
2024 Q2	–	Sell	-10,639	Closed	-$16K	–	2230
2024 Q1	$16K	Buy	+10,639	New	+$14.7K	﹤0.01%	2026

Other funds holding BFRI

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial's BFRI Position: Q2 2026 in Review

HRT Financial opened a new position in Biofrontera (BFRI) in Q2 2026: 43,349 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #3820 among its holdings. This is a return to the name: HRT Financial previously reported a position in BFRI as recently as Q2 2025.

HRT Financial first reported a position in BFRI in Q1 2024 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

HRT Financial held 43,349 shares of Biofrontera worth $40K as of Q2 2026.
Biofrontera was a new HRT Financial position in Q2 2026.
Biofrontera made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3820 holding.
HRT Financial first reported a position in Biofrontera in Q1 2024 and has held it in 3 quarters since.
19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.